Virus Hurts Nike's Results, Shares Undervalued
We expect to reduce our fair value estimate on the wide-moat brand because of COVID-19, but we believe it will come through the crisis better than most peers.
Nike (NKE) reported third-quarter sales and earnings that missed our expectations due to coronavirus-related shutdowns of its stores in greater China during February. The firm reported a 5% drop in sales in the region, well below recent results and our (pre-virus) forecast of 14% growth. Nike’s shares, though, rallied about 10% in post-market trading (after a 15% jump in the regular session) as the damage was less than feared and sales were strong in most regions. However, as the virus has since spread, the outlook for Nike’s fourth quarter is very murky and no guidance was provided. We expect to reduce our fair value estimate on Nike of $106 by a high-single-digit percentage because of COVID-19 and the likelihood of a global economic slowdown. However, we believe that Nike has a uniquely powerful brand, the source of our wide-moat rating, allowing it to come through the crisis better than most peers.
Nike’s total sales growth of 5.1% in the quarter missed our 7.9% forecast due to the shortfall in greater China. Constant-currency growth of 13% in Europe, the Middle East, and Africa, or EMEA, was well above our 6% forecast as Nike continues to take share from narrow-moat Adidas and others. While Nike’s North America growth of 4% fell short of our 6% forecast, it would have roughly met our view if not for the sale of the Hurley brand and another unusual event. Meanwhile, Nike reports that sales trends in greater China were favorable until the virus hit in February. Nike was able to cut some costs in response to the crisis, and its selling, general, and administrative expense margin of 32.5% beat our forecast of 33.1%. Overall, EPS of $0.53 missed our forecast of $0.71 but included a $0.25 one-time charge related to a change in its distribution in South America and the benefit of unusually low tax rate (3.9% versus our forecast of 14%). Nike probably would have beat our expectations if not for COVID-19.
|Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.|
David Swartz does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.